Regulatory scrutiny targets unexplained AI decisions within mission-critical simulations. In pharmaceuticals, aerospace, and energy, regulators like the FDA and FAA mandate a verifiable chain of reasoning for any automated decision that impacts safety or compliance. A digital twin's black-box AI model—whether a complex neural network or an ensemble method—fails this fundamental requirement.














